On air · 1 of 3 networks
Aiforia Technologies
- aiforia.com
- Healthcare & Life Sciences
- FI
- 81 employees
Aiforia Technologies’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 77. Watch Aiforia Technologies with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 35 | Checked 30 Oct 2026 | See all 77 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 16 Oct 2026 | Collect them with the API → |
| Not checked | — |
Aiforia Technologies has 35 live LinkedIn ads. Its Facebook page had no active ads on 16 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 26 Oct 2026
Breast Cancer Awareness Month is a powerful reminder of the vital role pathology plays in patient outcomes. But growing workloads demand faster, more consistent diagnostic insights. Aiforia’s Breast Cancer Suite–a comprehensive portfolio of CE-IVD marked AI models–empowers pathologists to deliver faster, more consistent, data-driven insights, improving diagnostic accuracy and patient outcomes. Learn more: https://lnkd.in/dApWDa3k/?utm_campaign=BCSuite%25E2%2580%2593Leadform%25E2%2580%2593Q42026&utm_source=linkedin&utm_medium=paid&utm_id=1229053903&hsa_acc=502575710&hsa_cam=1229053903&hsa_grp=896190383&hsa_ad=1592710023&hsa_net=linkedin&hsa_ver=3
- LINKEDIN · IMAGESince 23 Oct 2026
Elevate your pathology lab with Aiforia® Breast Cancer Suite – enhancing precision, speed, and diagnostic accuracy with cutting-edge AI technology. Aiforia® Breast Cancer Suite consists of AI models with an optimized interactive user interface that supports pathologists in the histological grading of breast cancer and in the assessment of breast cancer IHC markers. Request a demo to see a more detailed overview of the features. ⬇️
- LINKEDIN · IMAGESince 23 Oct 2026
Aiforia® Breast Cancer Suite offers advanced tools for histological grading and biomarker detection, ensuring precision and efficiency. - Aiforia® Breast Cancer Grading - Aiforia® Breast Cancer Ki67 - Aiforia® Breast Cancer ER - Aiforia® Breast Cancer PR - Aiforia® Breast Cancer HER2 - Aiforia® Lymph Node Metastasis Take the next step to see how AI seamlessly integrates to enhance every step, from sample analysis to diagnosis. ⬇️
- LINKEDIN · IMAGESince 23 Oct 2026
Aiforia® Breast Cancer Suite improves workflow efficiency and diagnostic accuracy in pathology labs. It consists of AI models and a matching Aiforia® Clinical Suite Viewer that support pathologists in the histological grading of breast cancer and in the assessment of breast cancer IHC markers. Request a demo to learn if it could optimize your current workflow. ⬇️
- LINKEDIN · IMAGESince 12 Oct 2026
In Aiforia's recent webinar, Pathologist Richard Doughty discussed how a pathologist and AI can work together and shared a practical view of what good AI–pathologist collaboration actually looks like. Watch the recording. ⬇️
- LINKEDIN · IMAGESince 12 Oct 2026
Watch Aiforia's webinar to learn more about Aiforia® Breast Cancer Suite, the most comprehensive AI toolkit for breast cancer diagnostics, supporting the entire diagnostic workflow. What you'll see: 🟣 How AI technology can enhance precision, speed, and diagnostic accuracy in breast cancer diagnostics. 🟣 A typical BC workflow with and without AI. 🟣 How Aiforia’s AI seamlessly integrates to enhance every step, from sample analysis to diagnosis. Get the recording. 👇🏼
6 of 77 adsSign up to see every Aiforia Technologies ad, filter by format and date, and get alerts on new ones.
See all 77 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.